Pasithea Therapeutics Corp.
KTTA
$1.19
-$0.02-1.65%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -7.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -7.78% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -18.75% | -14.31% | -19.15% | -20.61% | -5.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.51% | 13.28% | 22.48% | 26.93% | 41.42% |
| Operating Income | -8.51% | -13.28% | -22.48% | -26.93% | -41.62% |
| Income Before Tax | -8.45% | -8.36% | -17.54% | -32.23% | -106.26% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.45% | -8.36% | -17.54% | -32.23% | -106.26% |
| Earnings from Discontinued Operations | 98.87% | 99.11% | 91.73% | 79.45% | -31.20% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.60% | 3.63% | -2.42% | -14.53% | -95.77% |
| EBIT | -8.51% | -13.28% | -22.48% | -26.93% | -41.62% |
| EBITDA | -7.70% | -11.51% | -19.43% | -22.13% | -37.38% |
| EPS Basic | -20.74% | -15.26% | -14.29% | -19.31% | -94.41% |
| Normalized Basic EPS | -42.98% | -39.13% | -42.01% | -51.12% | -92.51% |
| EPS Diluted | -20.74% | -15.26% | -14.29% | -19.31% | -94.41% |
| Normalized Diluted EPS | -42.98% | -39.13% | -42.01% | -51.12% | -92.51% |
| Average Basic Shares Outstanding | -15.09% | -12.10% | -4.58% | 3.72% | 14.92% |
| Average Diluted Shares Outstanding | -15.09% | -12.10% | -4.58% | 3.72% | 14.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
